Ryosuke Tanino

510 total citations
25 papers, 379 citations indexed

About

Ryosuke Tanino is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Ryosuke Tanino has authored 25 papers receiving a total of 379 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 11 papers in Oncology and 10 papers in Molecular Biology. Recurrent topics in Ryosuke Tanino's work include Lung Cancer Treatments and Mutations (8 papers), Lung Cancer Research Studies (5 papers) and Cancer therapeutics and mechanisms (4 papers). Ryosuke Tanino is often cited by papers focused on Lung Cancer Treatments and Mutations (8 papers), Lung Cancer Research Studies (5 papers) and Cancer therapeutics and mechanisms (4 papers). Ryosuke Tanino collaborates with scholars based in Japan, China and Indonesia. Ryosuke Tanino's co-authors include Mamoru Harada, Yukari Tsubata, Takeshi Isobe, Tamio Okimoto, Yuichi Iida, Hitoshi Kotani, Rong Sun, Touko Inao, Yasuhisa Fujita and Nanae Harashima and has published in prestigious journals such as PLoS ONE, Scientific Reports and Oncotarget.

In The Last Decade

Ryosuke Tanino

20 papers receiving 375 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ryosuke Tanino Japan 11 172 118 92 59 54 25 379
Judong Luo China 11 256 1.5× 126 1.1× 90 1.0× 52 0.9× 82 1.5× 21 450
Mohammad Zulkifli United States 10 233 1.4× 92 0.8× 77 0.8× 38 0.6× 55 1.0× 18 524
Qiuyi Choo Singapore 9 221 1.3× 129 1.1× 56 0.6× 27 0.5× 56 1.0× 10 442
Yeon‐Mi Ryu South Korea 14 238 1.4× 190 1.6× 82 0.9× 67 1.1× 67 1.2× 29 602
Chunxia Huang China 15 231 1.3× 178 1.5× 53 0.6× 27 0.5× 48 0.9× 40 538
Yannan Yang China 4 260 1.5× 123 1.0× 162 1.8× 59 1.0× 145 2.7× 10 548
Sung-Won Shin South Korea 14 310 1.8× 111 0.9× 64 0.7× 21 0.4× 103 1.9× 24 553
R. Tyler Mertens United States 11 152 0.9× 146 1.2× 43 0.5× 58 1.0× 43 0.8× 20 390
Vojo Vukovic United States 7 277 1.6× 125 1.1× 99 1.1× 25 0.4× 81 1.5× 13 440

Countries citing papers authored by Ryosuke Tanino

Since Specialization
Citations

This map shows the geographic impact of Ryosuke Tanino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryosuke Tanino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryosuke Tanino more than expected).

Fields of papers citing papers by Ryosuke Tanino

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryosuke Tanino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryosuke Tanino. The network helps show where Ryosuke Tanino may publish in the future.

Co-authorship network of co-authors of Ryosuke Tanino

This figure shows the co-authorship network connecting the top 25 collaborators of Ryosuke Tanino. A scholar is included among the top collaborators of Ryosuke Tanino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryosuke Tanino. Ryosuke Tanino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Tanino, Ryosuke, et al.. (2025). Blood Concentrations of Osimertinib and Its Active Metabolites: Impact on Treatment Efficacy and Safety. Anticancer Research. 45(6). 2551–2561. 1 indexed citations
3.
Amano, Yoshimasa, Ryosuke Tanino, Rong Sun, et al.. (2025). Inhibition of Small-cell Lung Cancer Angiogenesis by Irinotecan Metronomic Chemotherapy and Irinotecan Plus Everolimus. Anticancer Research. 45(12). 5287–5297.
4.
Kotani, Hitoshi, Wei Han, Yuichi Iida, et al.. (2024). Therapeutic Senolysis of Axitinib-Induced Senescent Human Lung Cancer Cells. Cancers. 16(16). 2782–2782.
5.
Tanino, Ryosuke, Yukari Tsubata, T Hotta, et al.. (2023). Characterization of a spontaneous mouse model of mild, accelerated aging via ECM degradation in emphysematous lungs. Scientific Reports. 13(1). 10740–10740.
6.
Sun, Rong, Ryosuke Tanino, Minoru Isomura, et al.. (2022). The Association Between Cyclooxygenase-2 –1195G/A (rs689466) Gene Polymorphism and the Clinicopathology of Lung Cancer in the Japanese Population: A Case-Controlled Study. Frontiers in Genetics. 13. 796444–796444. 1 indexed citations
7.
Yoshioka, Wataru, et al.. (2022). Transient increase in plasma urate induced by a single oral dose of fructose in rats. Fundamental Toxicological Sciences. 9(7). 197–202.
8.
Kotani, Hitoshi, et al.. (2022). Protective roles of cytoplasmic p21Cip1/Waf1 in senolysis and ferroptosis of lung cancer cells. Cell Proliferation. 55(12). e13326–e13326. 12 indexed citations
9.
Kurimoto, Noriaki, et al.. (2022). Usefulness of endocytoscopy in evaluating transbronchial biopsy specimens. Thoracic Cancer. 14(2). 186–194. 1 indexed citations
10.
11.
Kawamura, Toshihiko, et al.. (2021). A Novel Model-Based Questionnaire Based on Low-Dose CT Screening Data for Chronic Obstructive Pulmonary Disease Diagnosis in Shimane, Japan. International Journal of COPD. Volume 16. 1823–1833. 3 indexed citations
12.
Okimoto, Tamio, Yukari Tsubata, Ryosuke Tanino, et al.. (2021). ERCC1 Is a Predictive Biomarker for Non-small Cell Lung Cancer But Is Antibody-dependent. Anticancer Research. 41(5). 2653–2660. 4 indexed citations
13.
Okimoto, Tamio, Hitoshi Kotani, Yuichi Iida, et al.. (2020). Pemetrexed sensitizes human lung cancer cells to cytotoxic immune cells. Cancer Science. 111(6). 1910–1920. 24 indexed citations
14.
Tanino, Ryosuke, Rong Sun, Yukari Tsubata, et al.. (2019). Anticancer Activity of ZnO Nanoparticles against Human Small-Cell Lung Cancer in an Orthotopic Mouse Model. Molecular Cancer Therapeutics. 19(2). 502–512. 86 indexed citations
15.
Tanino, Ryosuke, et al.. (2019). Protein tyrosine kinase 2: a novel therapeutic target to overcome acquired EGFR-TKI resistance in non-small cell lung cancer. Respiratory Research. 20(1). 270–270. 36 indexed citations
16.
Inao, Touko, Hitoshi Kotani, Yuichi Iida, et al.. (2019). Different sensitivities of senescent breast cancer cells to immune cell‐mediated cytotoxicity. Cancer Science. 110(9). 2690–2699. 31 indexed citations
17.
Iida, Yuichi, et al.. (2018). Chloroquine augments TRAIL-induced apoptosis and induces G2/M phase arrest in human pancreatic cancer cells. PLoS ONE. 13(3). e0193990–e0193990. 28 indexed citations
18.
Tanino, Ryosuke, Yukari Tsubata, Nanae Harashima, Mamoru Harada, & Takeshi Isobe. (2018). Novel drug-resistance mechanisms of pemetrexed-treated non-small cell lung cancer. Oncotarget. 9(24). 16807–16821. 26 indexed citations
19.
Inao, Touko, Yuichi Iida, Tamio Okimoto, et al.. (2018). Bcl-2 inhibition sensitizes triple-negative human breast cancer cells to doxorubicin. Oncotarget. 9(39). 25545–25556. 61 indexed citations
20.
Tsubata, Yukari, Mitsuhiro Hayashi, Ryosuke Tanino, et al.. (2017). Evaluation of the heterogeneous tissue distribution of erlotinib in lung cancer using matrix-assisted laser desorption ionization mass spectrometry imaging. Scientific Reports. 7(1). 12622–12622. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Judong Luo Breakdown of academic impact, for papers by Mohammad Zulkifli Breakdown of academic impact, for papers by Qiuyi Choo Breakdown of academic impact, for papers by Yeon‐Mi Ryu Breakdown of academic impact, for papers by Chunxia Huang Breakdown of academic impact, for papers by Yannan Yang Breakdown of academic impact, for papers by Sung-Won Shin Breakdown of academic impact, for papers by R. Tyler Mertens Breakdown of academic impact, for papers by Vojo Vukovic
Rankless by CCL
2026